-
Kizdar net |
Kizdar net |
Кыздар Нет
Sustaining pharmaceutical innovation after the Inflation Reduction Act ...
Jul 1, 2025 · Study shows robust commitment to innovation despite concern for future drug prices. There is concern that the drug …
Sustaining pharmaceutical innovation after the Inflation Reduction Act ...
Jun 1, 2025 · These results are indicative of a robust industry that continues to invest in innovation despite the prospects of …
Drug Discovery Today | Vol 30, Issue 7, July 2025 - ScienceDirect
Read the latest articles of Drug Discovery Today at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Research Studies & Reports - Bentley University
Numerous studies offer a framework for issues that the Center for the Integration of Science and Industry seeks to address. …
Sustaining pharmaceutical innovation after the Inflation Reduction Act ...
Aug 20, 2007 · The US Inflation Reduction Act (IRA) may not deter pharmaceutical innovation. Research and development spending, …
Fred D. Ledley | ScienceDirect
Apr 22, 2021 · This study examines the finances of 11 public companies that commercialize 21 out of the 25 drugs subject to price …
New research from the Center for Integration of Science and Industry at Bentley University found no evidence to support claims that …
F. Ledley - Semantic Scholar
Overall, reducing revenue from 21/25 drugs subject to price negotiation in 2024 or 2025 under the Inflation Reduction Act would not …
Biopharmaceutical Innovation Investment Endures Following Inflation
Jun 18, 2025 · The study, recently published in the journal Drug Discovery Today, analyzed a broad spectrum of industry activity …
Biopharmaceutical investment in innovation persists after passage of ...
Jun 18, 2025 · New research from the Center for Integration of Science and Industry at Bentley University found no evidence to …